R 75251, a new inhibitor of steroid biosynthesis
- PMID: 2164659
- DOI: 10.1002/pros.2990160409
R 75251, a new inhibitor of steroid biosynthesis
Abstract
R 75251, a new imidazole derivative, inhibited the conversion of androgens to estrogens, of progestins to androstenedione and testosterone, and of 11-deoxycorticosterone to corticosterone in human placenta microsomes, subcellular fraction of rat testis, bovine adrenocortical mitochondria, in cultured rat granulosa, testicular and adrenal cells, respectively. In vitro, no effect on cholesterol synthesis and cholesterol side-chain cleavage was found at concentrations up to 10 microM. In rat granulosa cells, no effect on progesterone production was detected. In vitro, no effect on steroid radioligand binding was observed. In male volunteers, a single dose of 300 mg of R 75251 significantly lowered plasma testosterone and estradiol for 24 hours and increased plasma concentration of 17 alpha-hydroxyprogesterone and progesterone. As compared with ketoconazole high dose (600 mg b.i.d), R 75251 (300 mg b.i.d) was at least as efficacious as inhibitor of testosterone synthesis when studied during ACTH stimulation. In contrast to ketoconazole, R 75251 did not significantly affect circulating adrenal androgen levels in male volunteers. Precursors of gluco- and mineralocorticoids such as 11-deoxycortisol and 11-deoxycorticosterone accumulated more than after ketoconazole administration. The data show that the cytochrome P450-dependent aromatase, 17-hydroxylase/17,20-lyase, and 11-hydroxylase are the target enzymes for R 75251.
Similar articles
-
Comparative effects of the aromatase inhibitor R76713 and of its enantiomers R83839 and R83842 on steroid biosynthesis in vitro and in vivo.J Steroid Biochem Mol Biol. 1990 Dec 20;37(6):1049-54. doi: 10.1016/0960-0760(90)90464-v. J Steroid Biochem Mol Biol. 1990. PMID: 2178362
-
Orteronel (TAK-700), a novel non-steroidal 17,20-lyase inhibitor: effects on steroid synthesis in human and monkey adrenal cells and serum steroid levels in cynomolgus monkeys.J Steroid Biochem Mol Biol. 2012 Apr;129(3-5):115-28. doi: 10.1016/j.jsbmb.2012.01.001. Epub 2012 Jan 12. J Steroid Biochem Mol Biol. 2012. PMID: 22249003
-
Low dose ketoconazole attenuates serum androgen levels in patients with polycystic ovary syndrome and inhibits ovarian steroidogenesis in vitro.Fertil Steril. 1994 May;61(5):823-32. doi: 10.1016/s0015-0282(16)56691-6. Fertil Steril. 1994. PMID: 8174717
-
[Inhibition of steroidogenesis by ketoconazole. Therapeutic uses].Ann Endocrinol (Paris). 1997;58(6):494-502. Ann Endocrinol (Paris). 1997. PMID: 9686009 Review. French.
-
P450-dependent enzymes as targets for prostate cancer therapy.J Steroid Biochem Mol Biol. 1996 Jan;56(1-6 Spec No):133-43. doi: 10.1016/0960-0760(95)00230-8. J Steroid Biochem Mol Biol. 1996. PMID: 8603034 Review.
Cited by
-
Liarozole.Drugs Aging. 1996 Dec;9(6):478-84; discussion 485. doi: 10.2165/00002512-199609060-00010. Drugs Aging. 1996. PMID: 8972247
-
Reliable Target Prediction of Bioactive Molecules Based on Chemical Similarity Without Employing Statistical Methods.Front Pharmacol. 2019 Jul 26;10:835. doi: 10.3389/fphar.2019.00835. eCollection 2019. Front Pharmacol. 2019. PMID: 31404334 Free PMC article.
-
Non-steroidal CYP17A1 Inhibitors: Discovery and Assessment.J Med Chem. 2023 May 25;66(10):6542-6566. doi: 10.1021/acs.jmedchem.3c00442. Epub 2023 May 16. J Med Chem. 2023. PMID: 37191389 Free PMC article. Review.
-
Effects of liarozole fumarate (R85246) in combination with tamoxifen on N-methyl-N-nitrosourea (MNU)-induced mammary carcinoma and uterus in the rat model.BMC Cancer. 2007 Jan 31;7:26. doi: 10.1186/1471-2407-7-26. BMC Cancer. 2007. PMID: 17266767 Free PMC article.
-
Retinoids as Chemo-Preventive and Molecular-Targeted Anti-Cancer Therapies.Int J Mol Sci. 2021 Jul 20;22(14):7731. doi: 10.3390/ijms22147731. Int J Mol Sci. 2021. PMID: 34299349 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
